Cover Image
市場調查報告書

Oxiracetam的中國市場

Investigation Report on China Oxiracetam Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 332304
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Oxiracetam的中國市場 Investigation Report on China Oxiracetam Market, 2010-2019
出版日期: 2015年06月04日 內容資訊: 英文 30 Pages
簡介

Oxiracetam打入中國市場以來其銷售量規模急速擴大,2005年不到2000萬人民幣的銷售量,到2014年已成長到12億3500萬人民幣的規模。

本報告提供中國的Oxiracetam市場規模與今後預測,提供您主要製藥公司及劑型別市場佔有率,銷售價格等資訊。

第1章 Oxiracetam的相關概念

  • 適應
  • 全球市場的銷售情形

第2章 中國Oxiracetam的市場簡介

  • Oxiracetam的專利及核準情況
  • 主要製藥公司
  • 市場規模

第3章 中國Oxiracetam銷售情形調查

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售數

第4章 中國Oxiracetam的主要製藥公司市場佔有率調查

  • 以銷售額為準的市場佔有率
  • 以銷售量為準的市場佔有率

第5章 中國Oxiracetam的劑型的相關調查

  • 劑型別市場佔有率:以銷售額為準
  • 劑型別市場佔有率:以銷售量為準

第6章 中國醫院的Oxiracetam的標準價格

  • CSPC Ouyi Pharmaceutical Co., Ltd (Ou Lai Ning)
  • Hunan Jianlang Pharmaceutical Co., Ltd (Jian Lang Xing)
  • Harbin Medisan Pharmaceutical Co., Ltd (Ou Lan Tong)
  • Guangdong SENCEE Pharmaceutical Co., Ltd (Bei Qing Xing)

第7章 中國市場中Oxiracetam的主要製藥公司

  • CSPC Ouyi Pharmaceutical Co., Ltd
  • Hunan Jianlang Pharmaceutical Co., Ltd
  • Harbin Medisan Pharmaceutical Co., Ltd
  • Guangdong SENCEE Pharmaceutical Co., Ltd

第8章 中國Oxiracetam的市場預測

  • 市場規模的預測
  • 競爭情形的預測
目錄
Product Code: 1506197

According to the National bureau of statistics of China, by the end of 2014, the number of Chinese aged above 60 years old is 212.42 million, occupying 15.5% of the total population; the number of Chinese aged above 65 is 137.55 million, occupying 10.1% of the total population. Senile dementia poses a serious threat to old people. According to statistics, about 10% of people aged above 60 suffer from senile dementia, among which 5% have Alzheimei's Disease (AD). In China, the number of senile dementia cases is estimated to be over 10 million and the incidence of AD doubles for every 5 years of age. There are about 20% of sick old people aged between 80-85 suffer from senile dementia, which strains their families as well as the society.

Oxiracetam, a derivative of pyrrolidone, was first synthesized by ISF in 1974. It is a nootropic drug whose oral preparation and injection entered the Italian market respectively in 1987 and 1990.

Oxiracetam develops fast after entering China, annual sales rising from less than 20 million in 2005 to 1.235 billion in 2014 and CAGR reaching up to 60% during the period of 2005-2014. Oxiracetam enjoys a vast demand in China. Products from CSPC Ouyi Pharmaceutical Co., Ltd, Hunan Jianlang Pharmaceutical Co., Ltd, Harbin Medisan Pharmaceutical Co., Ltd and Guangdong SENCEE Pharmaceutical Co., Ltd all occupy certain share of the market, among which Guangdong SENCEE has the largest market share of 34.16% with sales revenue reaching up to CNY 422 million in 2014.

As the ageing of population becomes more and more serious in China, senile dementia increasingly becomes a severe social problem. The market size of oxiracetam in China is expected to keep growing in the next few years.

Readers can get at least the following information through this report:

  • market share of manufacturers of oxiracetam in Chinese market
  • price of oxiracetam in Chinese market
  • major manufacturers of oxiracetam in China
  • share of different dosage forms of oxiracetam in Chinese market
  • market outlook of oxiracetam in China

The author suggests the following groups of people purchase this report:

  • manufacturers of nootropic drugs
  • investors/ research institutions interested in Chinese medicine market
  • any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Oxiracetam

  • 1.1. Indicaiton
  • 1.2. Sales Status in Global Market

2. Market Profile of Oxiracetam in China

  • 2.1. Patent and Approval Status of Oxiracetam in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Oxiracetam in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Oxiracetam in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Oxiracetam in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Oxiracetam in Chinese Hospitals in 2014

  • 6.1. CSPC Ouyi Pharmaceutical Co., Ltd (Trade Name: Ou Lai Ning)
  • 6.2. Hunan Jianlang Pharmaceutical Co., Ltd (Trade Name: Jian Lang Xing)
  • 6.3. Harbin Medisan Pharmaceutical Co., Ltd (Trade Name: Ou Lan Tong)
  • 6.4. Guangdong SENCEE Pharmaceutical Co., Ltd (Trade Name: Bei Qing Xing)

7. Major Manufacturers of Oxiracetam in the Chinese Market, 2010-2014

  • 7.1. CSPC Ouyi Pharmaceutical Co., Ltd
  • 7.2. Hunan Jianlang Pharmaceutical Co., Ltd
  • 7.3. Harbin Medisan Pharmaceutical Co., Ltd
  • 7.4. Guangdong SENCEE Pharmaceutical Co., Ltd

8. Market Outlook of Oxiracetam in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Patent Status of Oxiracetam in China
  • Chart Approval Information of Oxiracetam in China
  • Chart Sales Status of Oxiracetam in China, 2010-2014
  • Chart Sales Value of Oxiracetam in China, 2010-2014
  • Chart Sales Value of Oxiracetam in Some Regions in China, 2010-2014
  • Chart Sales Volume of Oxiracetam in China, 2010-2014
  • Chart Sales Value and Market Share of Oxiracetam Made by Harbin Medisan in China, 2010-2014
  • Chart Sales Value and Market Share of Oxiracetam Made by Guangdong SENCEE in China, 2010-2014
  • Chart Sales Value and Market Share of Oxiracetam Made by Hunan Jianlang in China, 2010-2014
  • Chart Sales Value and Market Share of Oxiracetam Made by CSPC Ouyi in China, 2010-2014
  • Chart Market Share of TOP4 Manufacturers of Oxiracetam by Sales Volume in China, 2010-2014
  • Chart Sales Value and Market Share of Oxiracetam Injections in China, 2010-2014
  • Chart Sales Value and Market Share of Oxiracetam Capsules in China, 2010-2014
  • Chart Price of Oxiracetam Made by CSPC Ouyi Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Oxiracetam Made by Hunan Jianlang Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Oxiracetam Made by Harbin Medisan Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Oxiracetam Made by Guangdong SENCEE Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top